ESR1 Mutations Tied to Worse Survival in Metastatic Breast CA

This article originally appeared here.
Share this content:
<i>ESR1</i> Mutations Tied to Worse Survival in Metastatic Breast CA
ESR1 Mutations Tied to Worse Survival in Metastatic Breast CA

THURSDAY, Aug. 11, 2016 (HealthDay News) -- For patients with estrogen receptor (ER)-positive metastatic breast cancer (MBC), estrogen receptor α (ESR1) mutations are prevalent and associated with shorter overall survival, according to a study published online Aug. 11 in JAMA Oncology.

Sarat Chandarlapaty, M.D., Ph.D., from the Memorial Sloan Kettering Cancer Center in New York City, and colleagues analyzed cell-free DNA from baseline plasma samples from participants in the BOLERO-2 double-blind phase 3 study that randomized women with MBC to exemestane plus placebo or exemestane plus everolimus. Baseline plasma samples were available for 541 patients. The authors examined the effect of mutation on overall survival and progression-free survival (PFS). The two most frequent mutations in ESR1 (Y537S and D538G) were analyzed using droplet digital polymerase chain reaction; samples were scored as wild type, Y537S, D538G, or double mutants.

The researchers found that 28.8 percent of patients had ESR1 mutations (21.1 percent D538G and/or 13.3 percent Y537S) and 30 patients had both mutations. These mutations correlated with shorter overall survival (wild type: 32.1 months; D538G: 25.99 months; Y537S: 19.98 months; both mutations: 15.15 months). The PFS benefit was similar for the D538G group and wild type with addition of everolimus to exemestane (hazard ratio, 0.34).

"ESR1 mutations are prevalent in ER-positive aromatase inhibitor-treated MBC," the authors write. "Both Y537S and D538G mutations are associated with more aggressive disease biology."

Several authors disclosed financial ties to Novartis, which funded the BOLERO-2 study and analysis performed in this work. One author disclosed ties to AstraZeneca.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease


Sign up for myCME e-newsletters


More in Home

24-Hour Primary Care Clinics Would Improve Continuity of Care

24-Hour Primary Care Clinics Would Improve Continuity of ...

Model involving multiple doctors working shifts in their own clinic offers many benefits

Repeat BP Reading Needed in Children With Initial High Result

Repeat BP Reading Needed in Children With Initial ...

Based on initial reading, more than half of children would have incorrect classification

Brochure Can Improve Opioid Disposal Rates After Surgery

Brochure Can Improve Opioid Disposal Rates After Surgery

Patients more likely to dispose of unused opioids after getting information and recommendations

is free, fast, and customized just for you!

Already a member?

Sign In Now »